|
LOC493754 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.202400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.922150E-03 |
| Normal-vs-Stage2 |
1.136800E-01 |
| Normal-vs-Stage3 |
9.337000E-01 |
| Normal-vs-Stage4 |
4.501200E-01 |
| Stage1-vs-Stage2 |
7.864200E-01 |
| Stage1-vs-Stage3 |
1.039580E-02 |
| Stage1-vs-Stage4 |
3.673800E-01 |
| Stage2-vs-Stage3 |
1.312790E-01 |
| Stage2-vs-Stage4 |
4.969000E-01 |
| Stage3-vs-Stage4 |
5.594400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.302140E-03 |
| Normal-vs-AfricanAmerican |
2.378800E-03 |
| Normal-vs-Asian |
8.227400E-01 |
| Caucasian-vs-AfricanAmerican |
7.115800E-01 |
| Caucasian-vs-Asian |
3.657000E-01 |
| AfricanAmerican-vs-Asian |
2.424800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.154400E-04 |
| Normal-vs-Female |
6.377000E-03 |
| Male-vs-Female |
8.731200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.573700E-02 |
| Normal-vs-Extreme_Weight |
9.606300E-04 |
| Normal-vs-Obese |
7.776600E-03 |
| Normal-vs-Extreme_Obese |
7.146600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.816600E-01 |
| Normal_Weight-vs-Obese |
6.752400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.224800E-01 |
| Extreme_Weight-vs-Obese |
3.881800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.381000E-01 |
| Obese-vs-Extreme_Obese |
3.212400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.351800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.978000E-04 |
| Normal-vs-Age(61-80Yrs) |
5.156900E-03 |
| Normal-vs-Age(81-100Yrs) |
9.105400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.136200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.432200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.745200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.503250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.140390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.906650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.48449999859812E-08 |
| Normal-VS-Type2 PRCC |
2.174000E-01 |
| Normal-VS-KIRP CIMP |
9.807800E-01 |
| Normal-VS-Unclassified PRCC |
1.733400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.44089209850063E-15 |
| Type1 PRCC-VS-KIRP CIMP |
2.06689999999732E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.162500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.170000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.756500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.915210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.698200E-01 |
| Normal-vs-N1 |
5.549600E-01 |
| Normal-vs-N2 |
2.657600E-01 |
| N0-vs-N1 |
9.459200E-01 |
| N0-vs-N2 |
9.659500E-02 |
| N1-vs-N2 |
4.376000E-01 |
|
|
